ClinicalTrials.gg
CompletedNCT03347643Updated Mar 24, 2020

The Effectiveness of tDCS on Internet Game Addiction

A Phase 2 interventional study of tDCS with real stimulation and tDCS with sham stimulation in Addiction and Internet Gaming Disorder, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2020-03-24.

Primary conditionInternet Addiction DisorderRegistry: Behavior, AddictiveReclassifiedWhy we changed it
Registry
Behavior, Addictive — the first condition term the registry derived for this study.
ClinicalTrials.gg
Internet Addiction Disorder
Why
  1. Behavior, Addictive is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Internet Addiction Disorder, a narrower term within Behavior, Addictive.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Seoul National University Hospital · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

In this study, the investigators aimed to investigate the effect of transcranial direct current stimulation (tDCS) on clinical status of Internet game addiction. The clinical status of Internet game addiction includes severity of addiction symptom, subjective craving for gaming, response inhibition and cue reactivity. The investigators hypothesized that real stimulation with tDCS on the dorsolateral prefrontal cortex will have higher effectiveness on severity of addiction symptom, subjective craving for gaming, response inhibition and cue reactivity rather than sham stimulation with tDCS.

02

Conditions studied

  • Addiction
  • Internet Gaming Disorder

Browse trials for

Keywords

  • Internet game addiction
  • Internet gaming disorder
  • transcranial direct current stimulation
  • response inhibition
  • craving
  • cue reactivity
03

In context

Internet Addiction Disorder Reclassified

166 studies on the registry are indexed under Internet Addiction Disorder; 47 are open to participants now.

This study's enrollment of 31 is below the median of 88 across 96 interventional studies indexed under Internet Addiction Disorder.

Browse Internet Addiction Disorder studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,900 studies on the registry; 274 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Compared within Internet Addiction Disorder, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Behavior, Addictive. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of Internet gaming disorder based on diagnostic criteria of (DSM)-5.

Exclusion criteria

Exclusion Criteria:

  • History of seizure
  • History of significant head injury
  • Mental retardation
  • Schizophrenia
  • History of stroke
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
31 participants (actual)

Study arms

  • Active comparator
    tDCS with real stimulation

    A total of 25 patients will be allocated into active comparator with real stimulation with tDCS.

    Device: tDCS with real stimulation

  • Sham comparator
    tDCS with sham stimulation

    A total of 25 patients will be allocated into sham comparator with sham stimulation with tDCS.

    Device: tDCS with sham stimulation

Interventions

  • DevicetDCS with real stimulation

    tDCS is a non-invasive brain stimulation. Real stimulation includes 2mA current for 20 minutes per session. Two sessions a day for 5 consecutive days (Total: 10 sessions) will be applied.

  • DevicetDCS with sham stimulation

    Sham stimulation includes 0mA current for 20 minutes per session. Two sessions a day for 5 consecutive days (Total: 10 sessions) will be applied.

06

What researchers measure

Primary outcomes

  1. Young Internet Addiction Test (Y-IAT)

    The Y-IAT is rated on a five-point scale. Total scores for all 20 items range from 20 to 100.

    Time frame: baseline

  2. Young Internet Addiction Test (Y-IAT)

    The Y-IAT is rated on a five-point scale. Total scores for all 20 items range from 20 to 100.

    Time frame: 1 week

  3. Young Internet Addiction Test (Y-IAT)

    The Y-IAT is rated on a five-point scale. Total scores for all 20 items range from 20 to 100.

    Time frame: 5 week

  4. Young Internet Addiction Test (Y-IAT)

    The Y-IAT is rated on a five-point scale. Total scores for all 20 items range from 20 to 100.

    Time frame: 25 week

Secondary outcomes

  1. Direction error and successful stop ratio in the Stop signal task

    The stop signal task is a neurocognitive task for assessing response inhibition.

    Time frame: baseline, 5 weeks, 25 weeks

  2. Barratt impulsiveness scale-11

    Barratt impulsiveness scale-11 is a self-report questionnaire consisting of 30 items. Each question has a 4-point scale ranging from 1 (rarely/never) to 4 (almost always/always). This scale scores three subscales: attentional impulsiveness, motor impulsiveness, and nonplanning impulsiveness. The total score ranges from 30 to 120 and higher scores indicate greater impulsivity.

    Time frame: baseline, 5 weeks, 25 weeks

  3. Anti-saccade error rate in the attentional bias task

    The attentional bias task is measured by anti-saccade task using eye-tracking analysis for assessing attentional bias on Internet gaming stimuli.

    Time frame: baseline, 5 weeks, 25 weeks

  4. Late positive potential in the cue reactivity event-related potential

    Event-related potential measures with cue reactivity task

    Time frame: baseline, 5 weeks, 25 weeks

  5. Visual analogue scale

    Subjective craving for Internet gaming ranging from 0 to 10. Higher score represents higher craving for gaming.

    Time frame: baseline, 1 week, 5 weeks, 25 weeks

07

Study locations

1 site
  • SMG-SNU Boramae Medical Center
    Seoul, 07061, Korea, Republic of
08

References and documents

Publications

  • Lee JY, Jang JH, Choi AR, Chung SJ, Kim B, Park M, Oh S, Jung MH, Choi JS. Neuromodulatory Effect of Transcranial Direct Current Stimulation on Resting-State EEG Activity in Internet Gaming Disorder: A Randomized, Double-Blind, Sham-Controlled Parallel Group Trial. Cereb Cortex Commun. 2021 Jan 4;2(1):tgaa095. doi: 10.1093/texcom/tgaa095. eCollection 2021. PubMed 34296150 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2017 to primary completion in Sep 2019, 23 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2017
First posted
Nov 20, 2017
StartActual
Sep 22, 2017
Primary completionActual
Sep 1, 2019
CompletionActual
Oct 8, 2019
Last update
Mar 24, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 24, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03347643
Collaborators
National Research Foundation of Korea, SMG-SNU Boramae Medical Center
Responsible party
Jung-Seok Choi (Clinical associate professor, Seoul National University Hospital) — Principal investigator
First posted
Nov 20, 2017
Start date
Sep 22, 2017
Primary completion
Sep 1, 2019
Completion
Oct 8, 2019
Last update
Mar 24, 2020

Study contacts

Jung-Seok Choi, MD, PhD
principal investigator · SMG-SNU Boramae Medical Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion